Home / Travoprost / United States
US ATC S01EE04 · updated 2 Nov 2026
Travoprost shortage in United States
Is there a Travoprost shortage in United States?
Yes. As of 2 Nov 2026, 2 Travoprost products are reported short in United States, the first since 7 Jul 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Spain, Belgium, Czechia, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 7 Jul 2026 | not given | Not stated |
| US | Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50) discontinuation | Mylan Pharmaceuticals Inc., a Viatris Company | 7 Jul 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).